CN Patent
CN1726915B — 盐酸纳洛酮鼻腔给药系统或组合物及其制备方法
Assigned to Institute of Pharmacology and Toxicology of AMMS · Expires 2013-04-24 · 13y expired
What this patent protects
本发明涉及盐酸纳洛酮鼻腔给药系统或组合物及其制备方法。确切地说本发明的鼻腔给药系统包括盐酸纳洛酮或其游离碱或纳洛酮的其它药用盐,吸收促进剂,渗透压调节剂,防腐剂,溶剂或其它药用辅料。
USPTO Abstract
本发明涉及盐酸纳洛酮鼻腔给药系统或组合物及其制备方法。确切地说本发明的鼻腔给药系统包括盐酸纳洛酮或其游离碱或纳洛酮的其它药用盐,吸收促进剂,渗透压调节剂,防腐剂,溶剂或其它药用辅料。
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.